Two patients were treated for inguinal hernia repair using Distalmotion’s Dexter Surgical Robot within 30 days of FDA De Novo ...

Distalmotion today announced the first successful U.S. outpatient procedures with its Dexter surgical robot platform.

Over 90% of hernia repairs are currently performed in the ASC setting, and the new robot is specifically tailored for those environments. The robot's design and form factor are both small, making it ...

Distalmotion has grabbed hold of a de novo clearance for its Dexter surgical robot, a system designed for hospitals as well as ambulatory surgery centers. The robotic assistant was cleared by the ...

Distalmotion’s Dexter Surgical Robot opens an entirely new era for soft tissue robotics in the outpatient setting and ambulatory surgery centers that will have immediate benefit for patients.

Swiss robotics company Distalmotion has seen its Dexter surgical robot, designed for adult inguinal hernia repair, granted De Novo marketing approval by the US Food and Drug Administration (FDA).

Lausanne, Switzerland, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Distalmotion has been granted De Novo approval by the U.S. Food and Drug Administration (FDA) to market the Dexter Surgical Robot for adult ...

Distalmotion has been granted De Novo approval by the U.S. Food and Drug Administration (FDA) to market the Dexter Surgical ...

Distalmotion's mission is to empower robotic surgery excellence by expanding access and improving care with robotic assisted surgery in the hospital outpatient and ambulatory surgery centers (ASC's) ...